Americans for Tax Reform

Americans for Tax Reform (ATR) stands firmly against any tax hikes as a fundamental belief. We advocate for a tax system that is straightforward, fair, transparent, and lower than current rates. We think that the government's influence over people's lives comes from its ability to impose taxes, and we believe that this influence should be reduced. ATR was established in 1985 by Grover Norquist at the invitation of President Reagan.

National

English

Online/Digital

Outlet metrics

Domain Authority

Ranking

Global

#1279383

United States

#306289

Law and Government/Government

#5665

Traffic sources

Monthly visitors

Articles

5 Myths About Medicaid Improvements in the One, Big, Beautiful Bill

2 weeks ago | atr.org | Isabelle Morales

This morning, in a huge victory for the American people, House Republicans passed the One, Big, Beautiful Bill (OBBB) Act. The bill will now move to the Senate, where it will face more scrutiny. Unfortunately, Democrats have made it their mission to lie about the reforms made in the OBBB, specifically regarding its Medicaid improvements.
Drug Pricing Executive Order Addresses a Real Problem with the Wrong Solution

3 weeks ago | atr.org | Isabelle Morales

Yesterday, President Trump signed an executive order entitled “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients.” Among a few other initiatives, this EO directs the Secretary of Health and Human Services to establish a mechanism through which Americans can buy their drugs directly from manufacturers at a “Most-Favored-Nation” (MFN) price.
ATR Submits Comments in Response to Section 232 Investigation of Pharmaceutical Imports

1 month ago | atr.org | Isabelle Morales

Today, Americans for Tax Reform submitted a public comment urging the Department of Commerce’s Bureau of Industry and Security to narrow their Section 232 national security investigation of pharmaceutical imports to adversarial trading partners. Tariffs and/or quotas on American allies would hurt patients and the U.S. pharmaceutical industry, threatening America’s global competitiveness.
Reconciliation Bill Should Improve Medicaid, Reject Price Controls

1 month ago | atr.org | Isabelle Morales

As the construction of this year’s reconciliation bill ramps up, Americans for Tax Reform urges members of Congress to take a well-measured approach to its healthcare provisions: improving on Medicaid and rejecting leftist price control measures. While some have been concerned about how the mainstream media will cover conservative Medicaid improvements, it is important to remember that Democrats will villainize this bill regardless of what is in it.
30+ Free Market Groups, Advocates Call for Repealing Green New Deal Subsidies in Reconciliation

1 month ago | atr.org | Isabelle Morales

Today, Americans for Tax Reform, with 31 other free market groups and advocates, released a coalition letter in support of repealing the Inflation Reduction Act’s green new deal subsidies in this year’s reconciliation bill. The letter highlights how the cost of these credits has rapidly increased in the past few years. Originally scored at $370 billion over ten years, these provisions are now projected to cost north of $1 trillion over a ten-year window.
Able-Bodied, Unemployed Adults Have Overrun the Medicaid Program

1 month ago | atr.org | Isabelle Morales

Medicaid – a program designed to help pregnant women, the disabled, the elderly, and children – has become overrun with able-bodied, unemployed adults. Today, a plurality of Medicaid spending goes towards able-bodied adults, with 62 percent of them not working, seeking education/training, nor volunteering. Not only does this push Medicaid spending into overdrive, but it depresses employment, subverts care away from those who need it most, and is an unpopular allocation of resources.
President Trump Signs EO to Lower Drug Prices, Boost Innovation

1 month ago | atr.org | Isabelle Morales

On April 15th, President Trump signed an executive order aimed at lowering prescription drug prices. This EO contains several provisions that will protect medical innovation and reduce the cost of medicine for Americans. Notably, these provisions include fixing the Inflation Reduction Act’s pill penalty, accelerating the approval of generics/biosimilars, and scrutinizing government spending on healthcare. President Trump should be applauded for making these important changes.
Paragon Institute: Survey Shows 81% of Voters Support Medicaid Work Requirements

2 months ago | atr.org | Isabelle Morales

The Paragon Institute recently published a survey focused on Americans’ attitudes regarding Medicaid reform. The survey found that Americans’ support for such reforms, like work requirements and moving one-half of Medicaid expansion recipients into the Obamacare exchanges, was high. To read the Paragon Institute survey results in full, click here. Lawmakers should take heed of these results.
MFN Drug Pricing Would Reduce Cures and Capitulate to China, Not End Foreign Freeloading

2 months ago | atr.org | Isabelle Morales

In recent months, a few policymakers and activists, not speaking on behalf of the Trump Administration, have called for the implementation of a Most Favored Nation (MFN) drug pricing model through the Center for Medicare and Medicaid Innovation (CMMI).
ATR Supports the Ensuring Pathways to Innovative Cures (EPIC) Act

2 months ago | atr.org | Isabelle Morales

In the Inflation Reduction Act (IRA), Democrats passed disastrous price controls on prescription drugs through a so-called “negotiation” process on behalf of Medicare. In addition to the many negative effects of this policy, including shortages, increased costs of other drugs, and reduction in R&D, the policy also created a small molecule “pill penalty,” disincentivizing the creation and sale of small molecule drugs.